Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Open in Screener

CARA

Cara Therapeutics Inc

May 17 • 04:00PM ET

0.7501

Dollar change -0.0551
Percentage change -6.84	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN SCHA VTWO VHT FESM IWC CNBS

Index	RUT	P/E	-	EPS (ttm)	-2.26	Insider Own	14.68%	Shs Outstand	54.48M	Perf Week	4.82%
Market Cap	41.02M	Forward P/E	-	EPS next Y	-0.88	Insider Trans	-1.03%	Shs Float	46.65M	Perf Month	8.71%
Income	-122.54M	PEG	-	EPS next Q	-0.27	Inst Own	43.75%	Short Float	5.60%	Perf Quarter	19.79%
Sales	16.94M	P/S	2.42	EPS this Y	43.20%	Inst Trans	-0.34%	Short Ratio	4.49	Perf Half Y	-33.03%
Book/sh	0.55	P/B	1.38	EPS next Y	29.42%	ROA	-100.70%	Short Interest	2.61M	Perf Year	-82.12%
Cash/sh	1.28	P/C	0.59	EPS next 5Y	-	ROE	-147.29%	52W Range	0.50 - 4.48	Perf YTD	0.96%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-1.20%	ROI	-163.38%	52W High	-83.26%	Beta	0.83
Dividend TTM	-	Quick Ratio	5.20	Sales past 5Y	115.17%	Gross Margin	73.75%	52W Low	50.02%	ATR (14)	0.07
Dividend Ex-Date	-	Current Ratio	5.38	EPS Y/Y TTM	-43.75%	Oper. Margin	-715.02%	RSI (14)	48.72	Volatility	11.08% 9.28%
Employees	55	Debt/Eq	1.52	Sales Y/Y TTM	-60.83%	Profit Margin	-723.49%	Recom	1.40	Target Price	5.12
Option/Short	Yes / Yes	LT Debt/Eq	1.52	EPS Q/Q	-13.60%	Payout	-	Rel Volume	0.43	Prev Close	0.81
Sales Surprise	26.80%	EPS Surprise	-40.70%	Sales Q/Q	-65.37%	Earnings	May 13 AMC	Avg Volume	582.16K	Price	0.75
SMA20	1.36%	SMA50	-6.99%	SMA200	-38.87%	Trades		Volume	251,899	Change	-6.84%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-08-23	Downgrade	BofA Securities	Neutral → Underperform	$13 → $6
Mar-08-22	Upgrade	JP Morgan	Neutral → Overweight	$17 → $20
Nov-01-21	Resumed	Canaccord Genuity	Buy	$33
Aug-03-21	Initiated	JP Morgan	Neutral	$16
Apr-21-20	Reiterated	H.C. Wainwright	Buy	$30 → $33
Aug-12-19	Reiterated	H.C. Wainwright	Buy	$31 → $30
May-29-19	Reiterated	Laidlaw	Buy	$26 → $32
Feb-06-19	Resumed	Jefferies	Buy	$22
Jan-15-19	Initiated	BofA/Merrill	Neutral	$19
Sep-21-18	Initiated	Cantor Fitzgerald	Overweight
Sep-13-18	Initiated	Jefferies	Buy	$30
Aug-08-18	Reiterated	Stifel	Buy	$22 → $26
Jun-28-18	Reiterated	H.C. Wainwright	Buy	$24 → $26
Mar-12-18	Resumed	H.C. Wainwright	Buy	$22
Feb-12-18	Upgrade	Janney	Neutral → Buy
Jan-19-18	Initiated	Seaport Global Securities	Buy	$27
Jun-30-17	Reiterated	Stifel	Buy	$24 → $20
Jun-30-17	Reiterated	Laidlaw	Buy	$35 → $30
Jun-30-17	Downgrade	Janney	Buy → Neutral
Mar-28-17	Reiterated	Laidlaw	Buy	$20 → $35

Show Previous Ratings

May-13-24 08:55PM	CARA Stock Earnings: Cara Therapeutics Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:10PM	Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:07PM	Cara: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Cara Therapeutics Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-06-24 07:00AM	Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 (GlobeNewswire)
07:00AM	Loading…
Apr-02-24 07:00AM	Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-07-24 07:00AM	Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024 (GlobeNewswire) +6.05%
06:40AM	7 F-Rated Stocks to Sell in March 2024 (InvestorPlace)
Mar-05-24 09:07AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript (Insider Monkey) -8.98%
07:51AM	Q4 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-04-24 08:51PM	CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) +5.24%
05:10PM	Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:21PM	Cara: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-12-24 04:01PM	Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024 (GlobeNewswire)
10:19AM	Loading…
Jan-22-24 10:19AM	Cara Layoffs 2024: What to Know About the Latest CARA Job Cuts (InvestorPlace)
07:00AM	Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026 (GlobeNewswire)
Dec-18-23 07:00AM	Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis (GlobeNewswire) -48.85%
Nov-14-23 11:04AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.20%
08:48AM	Q3 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-13-23 06:00PM	Cara (CARA) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +12.38%
04:15PM	Cara: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Cara Therapeutics Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-09-23 11:38AM	These Biotech Stocks Could Double Your Money, According To Analysts (Benzinga) -6.72%
Nov-06-23 10:00AM	Earnings Preview: Cara Therapeutics (CARA) Q3 Earnings Expected to Decline (Zacks)
Nov-02-23 07:00AM	Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty (GlobeNewswire)
Oct-23-23 07:00AM	Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023 (GlobeNewswire)
Sep-25-23 07:00AM	Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients (GlobeNewswire)
Sep-05-23 07:00AM	Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire) -10.00%
Aug-10-23 02:53AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript (Insider Monkey)
05:54AM	Loading…
Aug-08-23 05:54AM	Q2 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 05:15PM	Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.75%
04:09PM	Cara: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Cara Therapeutics Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 07:00AM	Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors (GlobeNewswire)
Aug-02-23 07:00AM	Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-24-23 07:00AM	Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire)
Jun-14-23 01:37PM	The past five years for Cara Therapeutics (NASDAQ:CARA) investors has not been profitable (Simply Wall St.)
Jun-13-23 06:30AM	3 Small-Cap Stocks to Sell in June Before They Crash and Burn (InvestorPlace)
Jun-02-23 06:46PM	Palo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Jun-01-23 07:00AM	Cara Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-30-23 06:34PM	7 Stocks With 1,000% Upside Potential (InvestorPlace)
May-25-23 06:40AM	Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark (Simply Wall St.) -6.55%
May-18-23 04:53PM	Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich or Broke. (InvestorPlace) -8.22%
02:00AM	Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus (PR Newswire)
May-16-23 11:02AM	Q1 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +7.23%
May-15-23 05:15PM	Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Cara: Q1 Earnings Snapshot (AP Finance)
04:01PM	Cara Therapeutics Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-04-23 09:38AM	Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 65% (Simply Wall St.)
May-01-23 07:00AM	Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 (GlobeNewswire)
Apr-26-23 08:00PM	CARA: What does Argus have to say about CARA? (Argus Research)
Apr-10-23 07:00AM	Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-07-23 08:41AM	We're Not Very Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate (Simply Wall St.)
Mar-14-23 07:00AM	Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report (GlobeNewswire)
Mar-11-23 07:19AM	Things Look Grim For Cara Therapeutics, Inc. (NASDAQ:CARA) After Today's Downgrade (Simply Wall St.)
Mar-08-23 06:59AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 10:46AM	Metas stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market (MarketWatch) -33.23%
10:02AM	Q4 2022 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
09:43AM	Cara Therapeutics stock sinks on larger-than-expected Q4 earnings miss (Yahoo Finance Video)
08:05AM	Meta shares rise after new wave of layoffs, WeightWatchers stock makes gains after results and acquisition; Grindrs stock falls after profit drop (MarketWatch)
Mar-06-23 07:39PM	These 2 Stocks Are Plunging After Hours Monday (Motley Fool)
05:15PM	Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-27-23 10:00AM	Will Cara Therapeutics (CARA) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-21-23 07:00AM	Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 (GlobeNewswire)
Feb-15-23 05:11AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.)
Feb-08-23 05:00PM	Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine (GlobeNewswire)
Jan-17-23 07:00AM	Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023 (GlobeNewswire)
Jan-03-23 07:00AM	Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-22 05:53AM	Cara Therapeutics (NASDAQ:CARA shareholders incur further losses as stock declines 8.8% this week, taking three-year losses to 35% (Simply Wall St.) +8.61%
Nov-29-22 07:30AM	KemPharm Announces Appointment of Christopher Posner as New Independent Director (GlobeNewswire)
Nov-09-22 06:08AM	Cara Therapeutics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-07-22 05:35PM	Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Cara Therapeutics Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-04-22 08:46AM	Why Cara Therapeutics (CARA) Might Surprise This Earnings Season (Zacks)
Nov-03-22 07:00AM	Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors (GlobeNewswire)
Nov-02-22 10:01AM	Analysts Estimate Affimed N.V. (AFMD) to Report a Decline in Earnings: What to Look Out for (Zacks) -5.80%
07:00AM	Cara Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-31-22 10:00AM	Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-30-22 08:51AM	Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 67% (Simply Wall St.)
Oct-24-22 07:00AM	Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022 (GlobeNewswire)
Oct-18-22 09:55AM	Wall Street Analysts See a 133% Upside in Cara (CARA): Can the Stock Really Move This High? (Zacks)
Oct-10-22 04:05PM	SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics (PR Newswire)
Sep-28-22 07:00AM	Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted in Japan (GlobeNewswire)
Sep-20-22 09:47AM	Here's Why We're Not Too Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Situation (Simply Wall St.)
Sep-12-22 07:00AM	Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer (GlobeNewswire)
Sep-08-22 02:27PM	Cara Therapeutics Presents Results of Oral Difelikefalin In Painful Itching Disorder (Benzinga)
08:15AM	Cara Therapeutics Presents Late-Breaking Results of the KOMFORT Phase 2 Trial of Oral Difelikefalin for Pruritus in Notalgia Paresthetica at the 31st EADV Congress (GlobeNewswire)
Sep-06-22 07:00AM	Cara Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-24-22 07:00AM	Cara Therapeutics to Host Virtual Notalgia Paresthetica Event on September 20, 2022 (GlobeNewswire)
Aug-22-22 07:00AM	Cara Therapeutics Announces KOMFORT Data Accepted for Late-Breaking Presentation at the 31st EADV Congress (GlobeNewswire)
Aug-19-22 01:00AM	Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022 (GlobeNewswire)
Aug-08-22 05:15PM	Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Cara Therapeutics Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-04-22 08:48AM	Should You Buy Cara Therapeutics (CARA) Ahead of Earnings? (Zacks) +12.26%
Aug-03-22 07:00AM	Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire) +7.02%
Aug-01-22 04:01PM	Cara Therapeutics to Announce Second Quarter 2022 Financial Results on August 8, 2022 (GlobeNewswire) -5.72%
Jul-28-22 09:14AM	10 Medical Marijuana Stocks to Buy Now (Insider Monkey)
Jul-22-22 06:39AM	Investors in Cara Therapeutics (NASDAQ:CARA) have unfortunately lost 56% over the last three years (Simply Wall St.)

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Posner Christopher	PRESIDENT AND CEO	May 02 '24	Sale	0.75	3,936	2,952	176,585	May 06 04:15 PM
Terrillion Scott	SEC'Y; CHIEF COMPLIANCE & G.C.	Apr 05 '24	Sale	0.83	2,753	2,285	88,247	Apr 09 04:21 PM
Goncalves Joana	CHIEF MEDICAL OFFICER	Apr 05 '24	Sale	0.83	2,753	2,285	53,365	Apr 09 04:22 PM
Posner Christopher	PRESIDENT AND CEO	Feb 29 '24	Sale	0.89	5,834	5,192	180,521	Mar 04 04:19 PM
Goncalves Joana	CHIEF MEDICAL OFFICER	Feb 29 '24	Sale	0.89	3,293	2,931	56,118	Mar 04 04:13 PM
Terrillion Scott	SEC'Y; CHIEF COMPLIANCE & G.C.	Feb 29 '24	Sale	0.89	3,293	2,931	91,000	Mar 04 04:24 PM
Posner Christopher	PRESIDENT AND CEO	Feb 08 '24	Sale	0.53	35,575	18,855	186,355	Feb 12 05:10 PM
Posner Christopher	PRESIDENT AND CEO	Feb 01 '24	Sale	0.55	4,981	2,740	221,930	Feb 05 04:26 PM
Posner Christopher	President and CEO	Nov 02 '23	Sale	1.22	3,796	4,631	164,411	Nov 03 04:37 PM
Posner Christopher	President and CEO	Aug 03 '23	Sale	3.07	4,307	13,222	168,207	Aug 04 05:21 PM
Menzaghi Frederique Ph.D.	Chief Scientific Off,SVP-R&D	Jun 23 '23	Sale	3.51	2,993	10,505	153,747	Jun 27 04:08 PM
Goncalves Joana	Chief Medical Officer	Jun 23 '23	Sale	3.51	2,723	9,558	53,681	Jun 27 04:07 PM
Terrillion Scott	Sec'y; Chief Compliance & G.C.	Jun 23 '23	Sale	3.51	2,483	8,715	88,563	Jun 27 04:09 PM

Open in Screener

IOVA

Iovance Biotherapeutics Inc

May 17 • 04:00PM ET

10.24

Dollar change -0.19
Percentage change -1.82	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB IWM VBR VXF IWN IBB SCHA VTWO VHT

Index	RUT	P/E	-	EPS (ttm)	-1.82	Insider Own	20.98%	Shs Outstand	256.14M	Perf Week	-6.61%
Market Cap	2.87B	Forward P/E	-	EPS next Y	-0.71	Insider Trans	9.89%	Shs Float	221.13M	Perf Month	-12.63%
Income	-449.64M	PEG	-	EPS next Q	-0.34	Inst Own	68.60%	Short Float	22.64%	Perf Quarter	11.91%
Sales	1.90M	P/S	1508.14	EPS this Y	32.03%	Inst Trans	-1.91%	Short Ratio	5.62	Perf Half Y	115.58%
Book/sh	2.43	P/B	4.21	EPS next Y	44.86%	ROA	-53.07%	Short Interest	50.06M	Perf Year	36.53%
Cash/sh	1.27	P/C	8.04	EPS next 5Y	-	ROE	-66.77%	52W Range	3.21 - 18.33	Perf YTD	25.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-8.25%	ROI	-59.69%	52W High	-44.14%	Beta	0.83
Dividend TTM	-	Quick Ratio	4.42	Sales past 5Y	0.00%	Gross Margin	-2251.94%	52W Low	219.00%	ATR (14)	0.80
Dividend Ex-Date	-	Current Ratio	4.63	EPS Y/Y TTM	24.46%	Oper. Margin	-24549.63%	RSI (14)	32.20	Volatility	6.23% 6.25%
Employees	557	Debt/Eq	0.12	Sales Y/Y TTM	-	Profit Margin	-23615.70%	Recom	1.31	Target Price	25.55
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	15.53%	Payout	-	Rel Volume	0.50	Prev Close	10.43
Sales Surprise	-64.76%	EPS Surprise	1.01%	Sales Q/Q	-	Earnings	May 09 AMC	Avg Volume	8.91M	Price	10.24
SMA20	-14.87%	SMA50	-22.09%	SMA200	19.44%	Trades		Volume	4,489,034	Change	-1.82%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-23	Initiated	Goldman	Buy	$12
Sep-18-23	Reiterated	Barclays	Overweight	$40 → $18
May-30-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$11 → $17
Mar-27-23	Resumed	Wells Fargo	Equal Weight	$11
Jan-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$11 → $14
Dec-09-22	Downgrade	Goldman	Buy → Neutral	$20 → $6
Oct-31-22	Initiated	Guggenheim	Neutral
Aug-18-22	Resumed	Wells Fargo	Equal Weight	$14
Jan-28-22	Upgrade	Stifel	Hold → Buy	$23 → $25
Dec-07-21	Resumed	Cowen	Outperform
Jun-10-21	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$32
May-20-21	Downgrade	Piper Sandler	Overweight → Neutral	$35 → $18
May-19-21	Downgrade	Stifel	Buy → Hold
May-19-21	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
May-03-21	Initiated	Truist	Buy	$50
Apr-16-21	Initiated	Goldman	Buy	$97
Mar-08-21	Upgrade	H.C. Wainwright	Neutral → Buy	$50
Dec-15-20	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-06-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-22-20	Initiated	Mizuho	Buy	$61

Show Previous Ratings

May-17-24 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
May-16-24 09:30AM	4 Small-Cap Value Stocks That Could Go Parabolic (Motley Fool)
May-13-24 02:25PM	Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained (MT Newswires)
12:42PM	Truist Adjusts Iovance Biotherapeutics' Price Target to $25 From $26, Keeps Buy Rating (MT Newswires)
May-11-24 10:00AM	The 3 Most Undervalued Biotech Stocks to Buy in May 2024 (InvestorPlace)
02:03PM	Loading…
May-10-24 02:03PM	Why Iovance Stock Is Down 18% Today (Motley Fool) -18.48%
01:35PM	Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says (MT Newswires)
12:55PM	Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ... (GuruFocus.com)
12:33PM	Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:25AM	Update: Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates (MT Newswires)
10:58AM	Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates (Zacks)
May-09-24 08:57PM	IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:27PM	Iovance Biotherapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:23PM	Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours (MT Newswires)
04:01PM	Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates (GlobeNewswire)
09:56AM	Loading…
May-06-24 09:56AM	Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect (Zacks)
May-01-24 06:01AM	Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024 (GlobeNewswire) +6.11%
Apr-30-24 06:01AM	Iovance Biotherapeutics to Present at Upcoming Conferences (GlobeNewswire)
Apr-28-24 02:44PM	Where Will Iovance Biotherapeutics Stock Be in 5 Years? (Motley Fool)
Apr-27-24 07:00AM	The Top 3 Biotech Stocks to Buy in April 2024 (InvestorPlace)
Apr-25-24 10:30AM	3 Millionaire-Maker Biotech Stocks (Motley Fool)
09:20AM	20 Counties with the Highest Cancer Rates in the US (Insider Monkey)
Apr-24-24 04:01PM	Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting (GlobeNewswire)
Apr-21-24 05:08AM	These Biotech Stocks Could Soar 120% and 295%, According to Wall Street (Motley Fool)
Apr-19-24 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-17-24 09:45AM	Is Iovance Biotherapeutics Stock a Buy Now? (Motley Fool)
Apr-08-24 01:51PM	Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why (Zacks)
Apr-05-24 05:03AM	Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics (Motley Fool)
Mar-29-24 11:30AM	Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-26-24 04:11AM	2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street (Motley Fool)
09:00AM	Loading…
Mar-23-24 09:00AM	U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies (The Wall Street Journal)
Mar-22-24 05:30PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-18-24 08:01PM	7 Biotech Stocks Ready to Ride the Sectors Resurgence (InvestorPlace)
02:00AM	Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead (Motley Fool)
Mar-15-24 08:18AM	Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks (Insider Monkey)
Mar-07-24 06:01AM	1 Wall Street Analyst Thinks Iovance Biotherapeutics Stock Is Going to $32. Is It a Buy Around $17? (Motley Fool)
Mar-06-24 04:42AM	Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst (Motley Fool)
Mar-05-24 01:00PM	FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study (Zacks)
Mar-04-24 06:30AM	Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer (GlobeNewswire)
Mar-02-24 06:50AM	Could Iovance Biotherapeutics Stock Help You Become a Millionaire? (Motley Fool)
Mar-01-24 05:00PM	Iovance Biotherapeutics to Present at Upcoming Conferences (GlobeNewswire) +5.53%
Feb-29-24 05:47PM	Why Iovance Biotherapeutics Stock Got Trounced on Thursday (Motley Fool) -8.72%
12:17PM	Q4 2023 Iovance Biotherapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
10:37AM	Iovance's (IOVA) Q4 Earnings & Sales Fall Short of Estimates (Zacks)
09:44AM	Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:51AM	Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy? (Motley Fool)
Feb-28-24 05:35PM	Iovance Biotherapeutics (IOVA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:42PM	Iovance Biotherapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:35PM	Iovance Biotherapeutics Inc (IOVA) Reports Q4 and Full Year 2023 Financial Results (GuruFocus.com)
04:01PM	Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates (GlobeNewswire)
Feb-27-24 08:52AM	Why Iovance (IOVA) Might Surprise This Earnings Season (Zacks) +5.24%
Feb-26-24 05:39AM	1 Soaring Growth Stock That Could Rise Another 53%, According to Wall Street (Motley Fool) +5.26%
Feb-25-24 08:07AM	Insiders Pour Millions Into These 2 Buy-Rated Stocks; Heres Why You Might Want to Follow Their Lead (TipRanks)
05:01AM	Is Iovance a Buy After Its First Regulatory Win? (Motley Fool)
Feb-23-24 06:14AM	This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst (Motley Fool)
Feb-22-24 08:45AM	Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024 (GlobeNewswire)
04:00AM	13 Best Short Squeeze Stocks To Buy Now (Insider Monkey)
Feb-20-24 03:38PM	Iovance Biotherapeutics Stock Rockets 30% Higher (Barrons.com) +31.48%
11:02AM	Why Iovance Biotherapeutics Stock Is Skyrocketing Today (Motley Fool)
08:00AM	WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance's AMTAGVI (lifileucel) for Advanced Melanoma (PR Newswire)
06:30AM	Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock (GlobeNewswire)
Feb-19-24 08:36AM	Iovance (IOVA) Stock Rises on FDA Nod for Melanoma Drug Amtagvi (Zacks)
Feb-16-24 05:30PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) -7.29%
04:04PM	UPDATE 3-US FDA grants accelerated approval for Iovance's skin cancer cell therapy (Reuters)
03:38PM	Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024 (GlobeNewswire)
03:35PM	FDA approves Iovance Biotherapeutics cell therapy for skin cancer (Reuters)
03:19PM	Iovance's AMTAGVI (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma (GlobeNewswire)
Feb-12-24 07:14AM	3 Opportunities for Iovance Biotherapeutics Stock, and 1 Risk (Motley Fool) +8.39%
Feb-08-24 07:27AM	Is Iovance Biotherapeutics Stock a Buy Now? (Motley Fool) +7.56%
Feb-07-24 05:10AM	Is Iovance Biotherapeutics a Buy Before This Key FDA Decision? (Motley Fool)
Feb-05-24 05:25AM	A Bull Market Is Here: 2 Top Growth Stocks to Buy Hand Over Fist (Motley Fool)
Feb-04-24 06:27AM	What's Next for Iovance Biotherapeutics Stock? (Motley Fool)
Jan-19-24 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-15-24 12:27PM	Iovance (IOVA) Surges More Than 150% in 3 Months: Here's Why (Zacks)
Jan-08-24 05:31AM	2 Growth Stocks That Could Rocket 149% to 210% Higher in 2024, According to Wall Street (Motley Fool) +12.87%
Dec-28-23 05:59PM	Why Iovance Biotherapeutics Stock Popped Today (Motley Fool) +18.67%
11:13AM	Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug (Zacks)
08:01AM	3 Charts For Investors to Watch Thursday: GC Education, Iovance, Ethereum (Investopedia)
Dec-27-23 05:26PM	Gold nears $2100, biotech stocks on the move: Trending tickers (Yahoo Finance Video) -18.67%
02:02PM	Iovance Stock Plunges on FDA News (Barrons.com)
12:21PM	Cytokinetics, New York Times rise; Iovance Biotherapeutics fall, Wednesday, 12/27/2023 (Associated Press Finance)
12:21PM	FDA Slaps Clinical Hold On Iovance Biotherapeutics' Lung Cancer Study After Patient Death (Benzinga)
11:21AM	Iovance Plummets as FDA Halts Cancer Drug Trial After Death (Bloomberg)
10:41AM	Iovance plunges as FDA halts lung-cancer-drug trial after patient death (TheStreet.com)
09:57AM	Iovance Stock Plunges as FDA Puts Hold on Lung Cancer Study After Patient Death (Barrons.com)
07:06AM	US FDA places clinical hold on Iovance's lung cancer treatment trial (Reuters)
07:00AM	Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer (GlobeNewswire)
Dec-22-23 05:15PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +5.70%
Dec-18-23 02:58PM	12 Most Promising Cancer Stocks According to Analysts (Insider Monkey)
Dec-12-23 08:45AM	Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? (Motley Fool)
05:29AM	A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street (Motley Fool)
Dec-07-23 11:31AM	Why Is Iovance Biotherapeutics (IOVA) Up 53% Since Last Earnings Report? (Zacks) +5.49%
Nov-20-23 12:00PM	Why Iovance Biotherapeutics Stock Is Jumping Today (Motley Fool) +8.71%
Nov-17-23 05:00PM	Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +14.77%
Nov-08-23 05:04PM	Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2023 Earnings Call Transcript (Insider Monkey)
01:03PM	Why Iovance Biotherapeutics Stock Is Marching Higher Today (Motley Fool)
07:55AM	Iovance's (IOVA) Meets Q3 Earnings, Lags Sales Estimates (Zacks)
Nov-07-23 04:26PM	Iovance Biotherapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2023 Financial Results and Corporate Updates (GlobeNewswire)
Oct-31-23 04:01PM	Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023 (GlobeNewswire)

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007, and is headquartered in San Carlos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vogt Frederick G	Interim CEO & General Counsel	Apr 15 '24	Option Exercise	0.00	20,834	0	150,185	Apr 17 07:08 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Apr 15 '24	Option Exercise	0.00	2,812	0	43,989	Apr 17 07:07 PM
BILINSKY IGOR	Chief Operating Officer	Apr 15 '24	Option Exercise	0.00	2,812	0	39,453	Apr 17 07:07 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Mar 04 '24	Option Exercise	0.00	15,623	0	49,230	Mar 06 06:20 PM
Vogt Frederick G	Interim CEO & General Counsel	Mar 04 '24	Option Exercise	0.00	41,662	0	140,800	Mar 06 06:19 PM
Rothbaum Wayne P.	Director	Feb 20 '24	Buy	9.15	5,000,000	45,750,000	28,067,333	Feb 20 04:11 PM
MCPEAK MERRILL A	Director	Feb 20 '24	Buy	9.15	250,000	2,287,500	320,150	Feb 20 07:52 PM
Dukes Iain D.	Director	Feb 20 '24	Buy	9.15	32,000	292,800	54,000	Feb 20 04:21 PM
Vogt Frederick G	Interim CEO & General Counsel	Jan 16 '24	Option Exercise	0.00	20,834	0	105,668	Jan 18 06:09 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Jan 16 '24	Option Exercise	0.00	2,813	0	35,184	Jan 18 06:09 PM
BILINSKY IGOR	Chief Operating Officer	Jan 16 '24	Option Exercise	0.00	2,813	0	31,444	Jan 18 06:07 PM
Vogt Frederick G	Interim CEO & General Counsel	Oct 16 '23	Option Exercise	0.00	20,835	0	93,685	Oct 18 08:05 PM
BILINSKY IGOR	Chief Operating Officer	Oct 16 '23	Option Exercise	0.00	2,813	0	30,026	Oct 18 08:04 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Oct 16 '23	Option Exercise	0.00	2,813	0	33,766	Oct 18 08:03 PM
MCPEAK MERRILL A	Director	Sep 18 '23	Buy	5.56	10,000	55,600	248,633	Sep 19 04:30 PM
Rothbaum Wayne P.	Director	Sep 15 '23	Buy	5.30	5,000,000	26,500,000	23,067,333	Sep 15 06:12 PM
GRAF FINCKENSTEIN FRIEDRICH	Chief Medical Officer	Jul 14 '23	Option Exercise	0.00	2,813	0	32,348	Jul 17 06:22 PM
Vogt Frederick G	Interim CEO & General Counsel	Jul 14 '23	Option Exercise	0.00	20,834	0	81,701	Jul 17 06:22 PM
BILINSKY IGOR	Chief Operating Officer	Jul 14 '23	Option Exercise	0.00	2,813	0	28,608	Jul 17 06:21 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

CARA

Cara Therapeutics Inc

IOVA

Iovance Biotherapeutics Inc

Upgrade your FINVIZ experience